Evox Therapeutics

Developer of exosome-based therapeutics for severe neurological and rare diseases

placeOxford, England, United Kingdom calendar_todayFounded 2016 groups73 employees language evoxtherapeutics.com

Registered entities

Innovation

33 patent families (8 granted) — focus: Human necessities, Chemistry & metallurgy, Mechanical engineering; filing pace slowing. Cited 737 times.

YearFilings
20164
20176
201812
201918
202015
202116
202215
202312
20249
20255
20262

Social engagement

Social engagement: 13.6K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

28 investors on record; lead investors include Gates, Redmile Group, Oxford Science Enterprises.

Investor typeCountShare
Venture capital621%
Private equity311%
Accelerator & incubator14%
Bank & private debt14%
Other / undisclosed1761%

Recent activity

20 Jun 2026
Event
BIO International Convention
26 May 2026
Event
UK Biotech Day 2026
4 May 2026
Event
Bio€quity Europe
Coming soon